Compare RUM & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RUM | AMPH |
|---|---|---|
| Founded | 2013 | 1996 |
| Country | United States | United States |
| Employees | N/A | 1976 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.0B |
| IPO Year | 2021 | 2005 |
| Metric | RUM | AMPH |
|---|---|---|
| Price | $8.53 | $26.25 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $28.38 |
| AVG Volume (30 Days) | ★ 5.0M | 387.8K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.72 | N/A |
| EPS | N/A | ★ 0.81 |
| Revenue | $100,622,320.00 | ★ $719,887,000.00 |
| Revenue This Year | $209.98 | $6.90 |
| Revenue Next Year | $40.99 | $4.64 |
| P/E Ratio | ★ N/A | $32.43 |
| Revenue Growth | ★ 5.38 | N/A |
| 52 Week Low | $4.62 | $16.65 |
| 52 Week High | $10.60 | $29.52 |
| Indicator | RUM | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 53.22 | 77.59 |
| Support Level | $5.74 | $25.53 |
| Resistance Level | $8.68 | $29.40 |
| Average True Range (ATR) | 0.56 | 0.84 |
| MACD | -0.03 | 0.18 |
| Stochastic Oscillator | 67.09 | 91.00 |
RUM Group Inc focused is to maximize the power of human imagination through an independent technology ecosystem built on privacy, resilience, and an open alternative to Big Tech. Rumble gives human creativity a voice, a video and media platform built for creators and audiences who value free expression. Quake AI is a cloud and AI-infrastructure business, delivering the compute, data-center capacity, and blockchain infrastructure for the agentic era.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.